2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4

被引:57
作者
Billamboz, Muriel [1 ,2 ]
Bailly, Fabrice [1 ,2 ]
Lion, Cedric [1 ,2 ]
Calmels, Christina [3 ]
Andreola, Marie-Line [3 ]
Witvrouw, Myriam [4 ,5 ]
Christ, Frauke [4 ,5 ]
Debyser, Zeger [4 ,5 ]
De Luca, Laura [6 ]
Chimirri, Alba [6 ]
Cotelle, Philippe [1 ,2 ]
机构
[1] Univ Lille Nord France, F-59000 Lille, France
[2] USTL, EA Chim Mol & Formulat 4478, F-59655 Villeneuve Dascq, France
[3] Univ Victor Segalen Bordeaux 2, CNRS, Inst Federatif Rech Pathol Infect & Canc IFR 66, MCMP UMR 5234, F-33076 Bordeaux, France
[4] Katholieke Univ Leuven, B-3000 Louvain, Flanders, Belgium
[5] IRC KULAK, B-3000 Leuven, Flanders, Belgium
[6] Univ Messina, Dipartimento Farmacochim, I-98168 Messina, Italy
关键词
2-Hydroxyisoquinoline-1,3(2H,4H)-dione; Integrase; Ribonuclease H; Magnesium complexation; Antiretroviral; ACTIVE-SITE; CATALYTIC DOMAIN; CRYSTAL-STRUCTURE; RIBONUCLEASE-H; VIRUS INTEGRASE; RALTEGRAVIR; SIMILARITY; COFACTOR; BINDING; DESIGN;
D O I
10.1016/j.ejmech.2010.11.033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report herein the synthesis of a series of fifteen 2-hydroxyisoquinoline-1,3(2H,4H)-dione derivatives. Alkyl and arylalkyl groups were introduced on position 4 of the basis scaffold. All the compounds presented poor inhibitory properties against HIV-1 reverse transcriptase ribonuclease H (RNase H). Four compounds inhibited HIV-1 integrase at a low micromolar level. A docking study using the later crystallographic data available for PFV integrase allowed us to explain the slightly improved integrase inhibitory activities of 4-pentyl and 4-(3-phenylpropyl)-2-hydroxyisoquinoline-1,3(2H,4H)-diones, when compared to the basis scaffold. Physicochemical studies were consistent with 1:1 and 1:2 (metal/ligand) stoichiometries of the magnesium complexes in solution. Unfortunately all tested compounds exhibited high cellular cytotoxicity in cell culture which limited their applications as antiviral agents. However these identified integrate inhibitors provide a very good basis for the development of new hits. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:535 / 546
页数:12
相关论文
共 41 条
  • [1] Al-Mawsawi LQ, 2008, EXPERT OPIN EMERG DR, V13, P213, DOI [10.1517/14728214.13.2.213, 10.1517/14728214.13.2.213 ]
  • [2] Closely related Antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase:: "Killing two birds with one stone"
    Andréola, ML
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (30) : 3713 - 3723
  • [3] Design, Synthesis, and Biological Evaluation of a Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain
    Billamboz, Muriel
    Bailly, Fabrice
    Barreca, Maria Letizia
    De Luca, Laura
    Mouscadet, Jean-Francois
    Calmels, Christina
    Andreola, Marie-Line
    Witvrouw, Myriam
    Christ, Frauke
    Debyser, Zeger
    Cotelle, Philippe
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (24) : 7717 - 7730
  • [4] The catalytic domain of human immunodeficiency virus integrase: Ordered active site in the F185H mutant
    Bujacz, G
    Alexandratos, J
    ZhouLiu, Q
    ClementMella, C
    Wlodawer, A
    [J]. FEBS LETTERS, 1996, 398 (2-3) : 175 - 178
  • [5] Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity
    Bujacz, G
    Alexandratos, J
    Wlodawer, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (29) : 18161 - 18168
  • [6] A cooperative and specific DNA-binding mode of HIV-1 integrase depends on the nature of the metallic cofactor and involves the zinc-containing N-terminal domain
    Carayon, Kevin
    Leh, Herve
    Henry, Etienne
    Simon, Francoise
    Mouscadet, Jean-Francois
    Deprez, Eric
    [J]. NUCLEIC ACIDS RESEARCH, 2010, 38 (11) : 3692 - 3708
  • [7] CHATTERJEA JN, 1972, J INDIAN CHEM SOC, V49, P1161
  • [8] CHATTERJEA JN, 1974, J INDIAN CHEM SOC, V51, P757
  • [9] CHATTERJEA JN, 1963, J INDIAN CHEM SOC, V40, P45
  • [10] Chatterjee J. N., 1960, J INDIAN CHEM SOC, V37, P443